REMASTER

What this means for you

This application is over — abandoned 07 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

90552860

Mark type

Stylized text

Filed

01 Mar 2021

Published for opposition

09 Nov 2021

Abandoned

07 Oct 2025

Attorney of record

Christina M. Licursi

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic pharmaceutical preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, rare and orphan diseases, and neurological diseases and disorders
• Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Scientific research, pharmaceutical research, medical research; Technical and scientific research consultation in the fields of biotechnology and development of pharmaceuticals; Product development for others in the fields of biotechnology and development of pharmaceuticals

Owner

• Remix Therapeutics Inc., Cambridge, MA, US
• Remix Therapeutics Inc., Cambridge, MA, US

Prosecution history

• 07 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 07 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
• 02 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 02 Jul 2024 — SOU EXTENSION 5 GRANTED
• 02 Jul 2024 — SOU EXTENSION 5 FILED
• 02 Jul 2024 — SOU TEAS EXTENSION RECEIVED
• 06 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 Jan 2024 — SOU EXTENSION 4 GRANTED
• 04 Jan 2024 — SOU EXTENSION 4 FILED
• 04 Jan 2024 — SOU TEAS EXTENSION RECEIVED
• 30 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 28 Jun 2023 — SOU EXTENSION 3 GRANTED
• 28 Jun 2023 — SOU EXTENSION 3 FILED
• 28 Jun 2023 — SOU TEAS EXTENSION RECEIVED
• 30 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED